Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
Similar Posts
Obesity can be dangerous for dogs, experts warn — here’s how to help your pudgy pup lose weight
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Ohio mother hopes for a cure to save her son, 8, from rare, fatal disease: ‘Gut-wrenching’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
AI-designed drug for inflammatory bowel disease enters human clinical trials: ‘A significant need’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
NHS consultants reject government's pay offer
Senior doctors in England reject proposed pay deal, as BMA union says offer “doesn’t go far enough”.
Zepbound is off to a strong start, but here’s what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly’s recently launched weight loss drug Zepbound. Investors will be tuning into the company’s fourth quarter earnings call on Feb. 6, eager to hear more about how that rollout is going. One key statistic will be the number of commercial health insurers providing coverage of the drug, which was approved…